Among the top-ranked differentially expressed genes between these two RNA-seq datasets, CELF2 and NR2F1 were consistently decreased in HR-deleted breast tumors (Figure 4A), but upregulated in HR-expressing MDA-MB-231 cells (Figure 4B). The gene discussed is CELF2; the disease is breast neoplasm.